Control Cohort CTRL COH

Last updated: January 9, 2025
Sponsor: Hospices Civils de Lyon
Overall Status: Active - Recruiting

Phase

N/A

Condition

Myasthenia Gravis (Chronic Weakness)

Amyotrophic Lateral Sclerosis (Als)

Joint Injuries

Treatment

Collection of biological sample (blood and/or CSF)

Clinical Study ID

NCT05370079
69HCL22_0275
  • Ages > 18
  • All Genders

Study Summary

Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from different disease to develop more specific diagnosis kit It could be possible through the characterisation of new genetic biomarkers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patient with consent

  • patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis,Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer,ovarian cancer, melanoma, thymoma), rheumatoid arthritis.

Exclusion

Exclusion Criteria:

  • refusal consent

  • patient with neurological disorder compatible with paraneoplastic neurologicalsyndrome or auto-immune encephalitis

  • patient under guardianship

Study Design

Total Participants: 350
Treatment Group(s): 1
Primary Treatment: Collection of biological sample (blood and/or CSF)
Phase:
Study Start date:
August 08, 2023
Estimated Completion Date:
August 08, 2028

Connect with a study center

  • Hospices Civils de Lyon

    Bron, 69500
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.